The FDA Wednesday approved the first drug to treat people with Prader-Willi syndrome, a rare genetic disease that causes an ...

Since 2000, when the FDA approved recombinant human growth hormone (rhGH) for those with the rare genetic disorder ...

First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome. Management to host conference call and webcast today, March 26 th, at 5:30pm ET. REDWOOD C ...

Shares of Soleno Therapeutics jumped 40% in morning trading on Thursday, after the company's drug for a rare metabolic condition became the first such treatment to receive U.S. regulatory nod.

Soleno on Wednesday said the FDA approved its Vykat XR extended-release tablets for the treatment of hyperphagia, a chronic and life-threatening feeling of intense, persistent hunger, in people ages 4 ...

Soleno Therapeutics (SLNO) “announced that the FDA has approved VYKAT XR, diazoxide choline, extended-release tablets, previously referred to ...

Cantor Fitzgerald raised the firm’s price target on Soleno Therapeutics (SLNO) to $123 from $67 and keeps an Overweight rating on the shares.

“Kudos to them that they knew what to look for.” Podcast: New lasso-shaped antibiotic kills drug-resistant bacteria The latest molecule targets bacteria’s protein-making factory, the ...

Becoming the first treatment for rare genetic disorder Prader-Willi syndrome (PWS), breakthrough therapy drug DCCR (diazoxide choline) gained U.S FDA approval as Vykat XR the evening before March 27, ...

Buying Cialis online can be simple and affordable. Here, we explore the five best platforms offering generic and branded Cialis based on medication price, ease of use, and our testers’ experiences.

However, there was insufficient evidence to say the drug was totally ineffective in ... Lymph Node Transfer Reduces Arm Swelling After Breast Cancer Surgery Mar. 18, 2025 — A study has shown ...